Stroke is a major health problem worldwide and is more recent published data show a treatment range of associated with high mortality and dependence. [1] In the 5-11% of incident ischemic stroke in USA and West next 30 years the burden of stroke will grow mostly in European nations. [17, 18] The proportion of patients developing countries rather than in developed receiving thrombolysis therapy in acute stroke is countries. [2] World Health Organization Monitoring Trends pathetically low in India. [19] The only incidence study of and Determinants in Cardiovascular Disease (WHO stroke in India determined an incidence of 163 per 100,000 MONICA) project [3] data showed relatively large populations per year (Dr. N. C. Borah personal geographical differences in stroke-related case-fatality communication). The expected number of incident rates, with the rates in less developed countries among ischemic strokes in India is 14, 43, 528 per year (assuming the highest in the world.
ischemic stroke account for 80% of all strokes and Indian The major development in the treatment of acute population in 2005: at 1,107 millions).
[20] Anticipated cost ischemic stroke has been the introduction of thrombolysis savings and health benefits (in terms of average QALYs) therapy (intravenous tissue plasminogen activator, tPA), [4] of thrombolysis therapy in India, even if a small proportion which has radically changed the perception and of patients are treated, will be enormous. The Indian management of stroke patients. Cochrane mata-analysis [5] regulatory authority has approved tPA for use in acute shows that thrombolysis therapy reduces death or ischemic stroke. There are centers with infrastructure and dependence by an odds ratio (OR) of 0.66 (95% confidence resources to give tPA widespread across the country. [19] It interval (CI) 0.53-0.83) with no significant increase in is feasible to give intravenous tPA for acute ischemic stroke adverse effects (OR 1.13; CI 0.86-1.48) for patients treated in India as shown by Padma and her colleagues [21] in this within 3h of the onset of an ischemic stroke. This issue of the journal and also by others. [19, 22] However there translates to one extra patient being alive and independent are several barriers for safe and effective implementation for every seven patients treated. The safety of routine of thrombolysis therapy in acute ischemic stroke in India. clinical use of tPA within 3h of stroke onset has been Most of the centers with infrastructure and resources confirmed in the Safe Implementation of Thrombolysis to give thrombolysis therapy are in urban India, where as in Stroke-Monitoring Study (SISTS-MOST).
[6] This study 80% of the population lives in rural India where the was designed to control for symptomatic intracerebral resources to give thrombolysis therapy are virtually nonhemorrhage, mortality and independence when compared to randomized controlled trials. Thrombolysis therapy has a very favorable economic profile; the therapy results in a net cost savings.
[7-10] When compared with standard acute stroke care, thrombolysis therapy provides, on average, greater health benefits (in terms of average quality adjusted life years, QALYs) at reasonable medical costs.
[11-14] The anticipated savings that would result from even modest, feasible increase in use of thrombolysis therapy is likely to be enormous. [15] In spite of good clinical efficacy and favorable economic profile, even in industrialized nations thrombolysis therapy is underutilized, only a very small proportion, 2%, of stroke patients are actually being treated. [7, 16] A existent. [19] Indian Collaborative Acute Stroke Study, urban hospital-based, has shown 7-24% of patients present to hospital within three hours of onset of stroke (unpublished data, 2004). One of the major reasons for the late arrival is delay in transportation. [23] [24] [25] There is hardly any ambulance service for transportation of the patients from rural India. Even in urban India transportation to the nearest hospital may not be in time.
In an urban hospital-based study in northwest India one of the factors for early arrival to stroke unit was living within a 10-km radius from the hospital.
[25]
The knowledge of stroke is quite low among the population. In a study in northwest India, majority (73%) of the subjects (including both patients and Murthy: Thrombolysis for stroke in India relatives) interviewed did not realize that the symptoms were due to stroke and only a third of the study cohort correctly identified the brain as the affected organ in stroke. In this study self-recognition of stroke symptoms by patients was only 27%.
[26] Low-threat perception of stroke was an independent factor for the late arrival of patients at the hospital in a study from north India.
[24]
Most of the rural patients with stroke attending a university hospital in south India were not aware of the importance of the time window in stroke management. [23] year) can have access to acute stroke care including thrombolysis therapy (Dr. N. C. homeopathic and ayurvedic treatment.
[27]
6. The SITS Collaborators. Thrombolysis for acute ischemic stroke:
The economic burden and loss of productivity caused therapy belonged to a lower socioeconomic status from 10. Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, rural India and could not afford the therapy. [23] In an urban Database Syst Rev the drug. [22] importance of window period and the benefits of thrombolysis therapy and 2) educating the public about stroke warning symptoms, risk factors, the mortality and dependence associated with stroke and importance of time window for thrombolysis treatment. For the safe implementation of thrombolysis in stroke in India, Indian Stroke Association has recently launched both SITSInternational Stroke Thrombolysis Register (SITS-ISTR) and SITS in Non European World (SITS-NEW). Even after increasing the awareness of stroke and thrombolysis among the people, in India still the affordability and poor healthcare infrastructure in the community for the safe implementation of thrombolysis remain formidable barriers for some time to come. Guwahati Neurological Research Center in Assam has initiated a novel approach, Stroke Help Card, to make stroke care affordable. ) .
